1. India Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
Genpharmasec Limited

Genpharmasec Limited

BBSE:GENPHARMA
1.02
INR
+0.03
(+3.03%)
-0.01EPS
609.09MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
- -
0.03
- -
0.88
0.15
0.01
0.46
0.46
0.58
0.55
0.59
0.61
2.53
3.08
Basic EPS, GAAP
0.04
0.04
0.18
0.03
0.09
0.01
0.03
0.03
- -
0.02
- -
0.03
0.03
-0.01
Free Cash Flow per Basic Share
0.03
0.05
0.19
-0.09
0.27
-0.18
0.04
-0.05
-0.05
-0.07
-0.06
-0.05
-0.33
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-1.92
-1.88
-1.7
-1.67
-1.59
0.6
0.53
0.45
0.33
0.33
1.16
1.18
1.2
- -
Tangible Book Value per Share
-1.92
-1.88
-1.7
-1.67
-1.59
0.6
0.53
0.45
0.33
0.33
1.16
1.18
0.87
- -
Basic Weighted Avg Shares
6
6
5
5
5
361
361
452
461
461
512
554
554
577
Sales/Revenue/Turnover
- -
- -
- -
5
1
4
165
208
266
253
304
337
1,399
1,776
Operating Margin (%)
- -
-1,815.7
- -
2.68
-31.68
-23.31
3.93
3.24
-4.68
0.31
1.42
-0.97
-0.33
-0.75
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
8
22
26
Net Income, GAAP
- -
- -
1
- -
- -
2
10
13
-2
11
-2
16
16
-6
Effective Tax Rate (%)
1.77
0.48
- -
- -
25.81
19.68
16.26
16.7
- -
- -
167.56
29.34
42.3
- -
Profit Margin (%)
- -
129.53
- -
3.21
58.5
61.56
6.12
6.05
-0.79
4.45
-0.56
4.7
1.15
-0.31
Working Capital
- -
- -
1
1
1
77
102
196
153
169
370
166
335
- -
LT Debt
11
11
10
10
10
- -
- -
- -
- -
25
39
48
253
- -
Total Equity
-10
-10
-9
-9
-9
216
190
207
154
153
645
653
656
- -
Return on Invested Capital (%)
-10.78
-859.98
- -
- -
-13.93
-0.65
2.66
2.82
- -
- -
-0.01
-0.2
-0.37
- -
Return on Capital (%)
6.08
61.64
- -
- -
36.04
2.13
4.97
6.34
- -
- -
-0.93
2.76
3.83
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
4.97
6.34
-1.16
7.33
-0.42
2.45
2.44
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
96
- -
LT Borrowings
- -
240
- -
LT Finance Leases
- -
14
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
554
554
554
Market Capitalization
725
432
609

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
805
- -
Cash, Cash Equivalents & STI
- -
101
- -
Accounts Receivable, Net
- -
293
- -
Inventories
- -
139
- -
Total Current Liabilities
- -
470
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
96
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-231.63%
59.32%
0.56%
Free Cash Flow
-487.2%
117.09%
556.38%
Net Income, GAAP
-103.26%
-380.91%
1.12%
Sales/Revenue/Turnover
- -
73.82%
314.98%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
52
60
85
140
337
2026
120
326
398
554
1,399
2027
497
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.01
0.01
0.01
-0.01
0.03
2026
0.02
-0.02
-0.01
0.02
0.03
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Sohan Chaturvedi
Full Time Employees
13
Sector
Process industries
Industry
Chemicals: specialty
Address
Office No. 104 & 105 Mumbai MA India 400101
IPO Date
Feb 5, 1996
Website
genpharmasec.com
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
PI Industries Limited (NSE:PIIND)
Business
Genpharmasec Limited operates within the healthcare domain, focusing on the distribution of advanced diagnostic equipment and offering laboratory testing services, alongside its involvement in equity share trading. The company's operations are structured across key segments including Diagnostic Pharma Equipment, Trading in Securities, and Laboratory Testing. Notably, it holds distribution rights for i-STAT Analyzers and associated cartridges from Abbott Point of Care, USA, catering to critical care units in hospitals across India, providing rapid blood analysis. Further expanding its footprint in healthcare, Genpharmasec is strategically acquiring a stake in Derren Healthcare Private Limited to venture into injectable manufacturing and has established Clinigenome India Private Limited as a wholly-owned subsidiary to develop a network of clinical laboratories throughout major Indian cities. The company was initially incorporated on November 16, 1992, and maintains its headquarters in Mumbai, India.